阳普医疗
(300030)
| 流通市值：21.75亿 | | | 总市值：24.70亿 |
| 流通股本：2.72亿 | | | 总股本：3.09亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 230,956,513.82 | 115,535,431.63 | 581,328,009.09 | 421,468,424.66 |
| 营业收入 | 230,956,513.82 | 115,535,431.63 | 581,328,009.09 | 421,468,424.66 |
| 二、营业总成本 | 224,023,221.08 | 113,052,570.94 | 570,559,674.48 | 413,928,591.21 |
| 营业成本 | 135,389,759.37 | 69,102,507.91 | 340,698,710.81 | 252,701,132.63 |
| 税金及附加 | 3,283,167.82 | 1,705,587.25 | 8,643,965.27 | 6,466,081.16 |
| 销售费用 | 32,409,165.2 | 16,180,384.62 | 93,881,936.52 | 57,981,219.67 |
| 管理费用 | 39,252,396.46 | 19,201,718.48 | 86,876,673.17 | 65,667,453.05 |
| 研发费用 | 11,712,995.01 | 6,107,098.1 | 31,899,035.5 | 23,376,301.59 |
| 财务费用 | 1,975,737.22 | 755,274.58 | 8,559,353.21 | 7,736,403.11 |
| 其中:利息费用 | 2,856,767.16 | 1,734,247.37 | 11,089,765.57 | 9,290,301.4 |
| 其中:利息收入 | 850,078.67 | 671,485.13 | 1,817,943.86 | 1,432,358.02 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 0 | - | -54,905,300 | -35,184,400 |
| 加:投资收益 | 10,984,135.17 | 4,353,325.29 | -8,652,614.47 | -12,979,218.06 |
| 资产处置收益 | -1,007,156.4 | 174,553.71 | 900,844.63 | 384,110.58 |
| 资产减值损失(新) | -34,052 | - | -47,201,039.26 | -166,748.49 |
| 信用减值损失(新) | -1,535,719.03 | - | -22,807,199.17 | -6,493,488.56 |
| 其他收益 | 2,923,858.14 | 1,520,363.72 | 4,968,066.27 | 6,022,099.69 |
| 四、营业利润 | 18,264,358.62 | 8,531,103.41 | -116,928,907.39 | -40,877,811.39 |
| 加:营业外收入 | 1,354,182.69 | 259,236.83 | 4,196,465.6 | 67,908.39 |
| 减:营业外支出 | 786,956.28 | 4,326.68 | 7,613,833.07 | 529,155.29 |
| 五、利润总额 | 18,831,585.03 | 8,786,013.56 | -120,346,274.86 | -41,339,058.29 |
| 减:所得税费用 | 3,396,273.71 | 931,065.73 | -447,112.98 | 3,293,277.28 |
| 六、净利润 | 15,435,311.32 | 7,854,947.83 | -119,899,161.88 | -44,632,335.57 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 15,435,311.32 | 7,854,947.83 | -119,899,161.88 | -44,632,335.57 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 15,266,563.13 | 7,808,417.76 | -117,903,784.23 | -42,517,592.38 |
| 少数股东损益 | 168,748.19 | 46,530.07 | -1,995,377.65 | -2,114,743.19 |
| 扣除非经常损益后的净利润 | 15,179,785.61 | 7,298,401.61 | -69,977,559.82 | -13,489,870.18 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.05 | 0.03 | -0.38 | -0.14 |
| (二)稀释每股收益 | 0.05 | 0.03 | -0.38 | -0.14 |
| 八、其他综合收益 | 4,030.67 | 558.24 | 1,553,766.86 | 17,683.97 |
| 归属于母公司股东的其他综合收益 | 4,030.67 | 558.24 | 1,553,766.86 | 17,683.97 |
| 九、综合收益总额 | 15,439,341.99 | 7,855,506.07 | -118,345,395.02 | -44,614,651.6 |
| 归属于母公司股东的综合收益总额 | 15,270,593.8 | 7,808,976 | -116,350,017.37 | -42,499,908.41 |
| 归属于少数股东的综合收益总额 | 168,748.19 | 46,530.07 | -1,995,377.65 | -2,114,743.19 |
| 公告日期 | 2025-08-15 | 2025-04-25 | 2025-04-25 | 2024-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |